Switching Therapy in Chronic Myeloid Leukemia
0 vistas
• 07/08/23
0
0
Empotrar
administrator
Suscriptores
The panelists, Jorge Cortes, MD; Javier Pinilla-Ibarz, MD, PhD; David Snyder, MD, FACP; and Harry Erba, MD, PhD, share perspectives on clinical scenarios in chronic myeloid leukemia that may prompt a treatment change.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios